Identification
- Generic Name
- 5,6-Diaminouracil
- DrugBank Accession Number
- DB03826
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for 5,6-Diaminouracil (DB03826)
- Weight
- Average: 142.116
Monoisotopic: 142.049075456 - Chemical Formula
- C4H6N4O2
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as pyrimidones. These are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Diazines
- Sub Class
- Pyrimidines and pyrimidine derivatives
- Direct Parent
- Pyrimidones
- Alternative Parents
- Aminopyrimidines and derivatives / Hydropyrimidines / Vinylogous amides / Heteroaromatic compounds / Ureas / Lactams / Azacyclic compounds / Primary amines / Organopnictogen compounds / Organooxygen compounds show 2 more
- Substituents
- Amine / Aminopyrimidine / Aromatic heteromonocyclic compound / Azacycle / Heteroaromatic compound / Hydrocarbon derivative / Hydropyrimidine / Lactam / Organic nitrogen compound / Organic oxide show 8 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- aminopyrimidine, pyrimidone (CHEBI:46252)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- VEU0FRO9FL
- CAS number
- Not Available
- InChI Key
- BBTNLADSUVOPPN-UHFFFAOYSA-N
- InChI
- InChI=1S/C4H6N4O2/c5-1-2(6)7-4(10)8-3(1)9/h5H2,(H4,6,7,8,9,10)
- IUPAC Name
- 5,6-diamino-1,2,3,4-tetrahydropyrimidine-2,4-dione
- SMILES
- NC1=C(N)C(=O)NC(=O)N1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 76726
- PubChem Substance
- 46506688
- ChemSpider
- 69184
- BindingDB
- 50047398
- ChEBI
- 46252
- ChEMBL
- CHEMBL34076
- ZINC
- ZINC000001666585
- PDBe Ligand
- URN
- PDB Entries
- 1ws2 / 2h0j
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 13.8 mg/mL ALOGPS logP -1.5 ALOGPS logP -2.2 Chemaxon logS -1 ALOGPS pKa (Strongest Acidic) 8.48 Chemaxon pKa (Strongest Basic) -4.1 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 110.24 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 42.53 m3·mol-1 Chemaxon Polarizability 12.08 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.8758 Blood Brain Barrier + 0.9489 Caco-2 permeable - 0.6472 P-glycoprotein substrate Non-substrate 0.7094 P-glycoprotein inhibitor I Non-inhibitor 0.9661 P-glycoprotein inhibitor II Non-inhibitor 1.0 Renal organic cation transporter Non-inhibitor 0.9522 CYP450 2C9 substrate Non-substrate 0.8118 CYP450 2D6 substrate Non-substrate 0.8324 CYP450 3A4 substrate Non-substrate 0.7893 CYP450 1A2 substrate Non-inhibitor 0.8456 CYP450 2C9 inhibitor Non-inhibitor 0.9675 CYP450 2D6 inhibitor Non-inhibitor 0.9763 CYP450 2C19 inhibitor Non-inhibitor 0.9388 CYP450 3A4 inhibitor Non-inhibitor 0.959 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9955 Ames test Non AMES toxic 0.7454 Carcinogenicity Non-carcinogens 0.9452 Biodegradation Not ready biodegradable 0.846 Rat acute toxicity 2.0030 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9582 hERG inhibition (predictor II) Non-inhibitor 0.9194
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 126.092622 predictedDarkChem Lite v0.1.0 [M-H]- 125.917694 predictedDeepCCS 1.0 (2019) [M+H]+ 127.145822 predictedDarkChem Lite v0.1.0 [M+H]+ 129.33357 predictedDeepCCS 1.0 (2019) [M+Na]+ 138.24141 predictedDeepCCS 1.0 (2019)
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52